Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat Open-Label Extension in CKD Anemia
NCT01630889Phase 2Completed
- Sponsor
- FibroGen
- Start
- May 2012
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of roxadustat in anemia, sponsored by FibroGen. Started May 2012; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01630889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01630889.